Physician profile
Jonathan Eucker
NPI 1417952276
$49,979.28
in general payments reported to CMS, 2019-2025
24 companies · $540 in 2025
The $540 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,387 · 2020: $4,349 · 2021: $13K · 2022: $12K · 2023: $11K · 2024: $3,481 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Food and Beverage: $1,876 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,262.10 |
| Food and Beverage | $1,875.89 |
| Education | $139.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $34,304.55 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $12,311.94 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $632.10 | 2021-2025 | |
| Abbvie INC. | $559.38 | 2019-2024 | |
| Amgen INC. | $452.75 | 2019-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $407.48 | 2020-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $260.46 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $171.65 | 2021-2022 | |
| Therapeuticsmd, INC. | $122.42 | 2019-2022 | |
| Pfizer INC. | $109.14 | 2021-2024 | |
| Millicent US INC | $98.86 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $87.17 | 2019-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Agile Therapeutics, INC. | $85.60 | 2022-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $70.99 | 2022-2024 | |
| Evofem Biosciences, INC. | $51.00 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $48.29 | 2019 | |
| Avion Pharmaceuticals | $33.83 | 2022 | |
| Allergan, INC. | $33.74 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $33.20 | 2020-2022 | |
| Lupin INC. | $29.84 | 2019-2020 | |
| Exeltis, USA INC. | $28.68 | 2024 | Slynd |
| Exact Sciences Corporation | $22.21 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $13.05 | 2020 | |
| Covidien Lp | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Eucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.